PLAT and chronic thromboembolic pulmonary hypertension: The systemic fibrinolysis pathway is typically considered not to be affected in CTEPH, but imbalances in local expression of tissue-type plasminogen activator (tPA) and type 1 plasminogen activator inhibitor (PAI-1) have been observed [36,37].